Catalyst Wire Dossier Catalyst Wire Dossier

Lenalidomide Krka d.d. Novo mesto

lenalidomide hydrochloride monohydrate · Krka, d.d., Novo mesto
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lenalidomide Krka d.d. Novo mesto, covering 2021-12-17 to 2021-12-17. Get the full timeline:

Most recent: EMA Authorised: Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) (lenalidomide hydrochloride monohydrate) — Krka, d.d., Novo mesto

See pricing